Dianthus Therapeutics, Inc. /DE/ (DNTH) Deferred Tax Assets, Net of Valuation Allowance USD 2017 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from 2017 to 2023.
  • Dianthus Therapeutics, Inc. /DE/ Deferred Tax Assets, Net of Valuation Allowance for the quarter ending December 31, 2023 was $13.3 M, a 6690% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $13.3 M +$13.1 M +6690% Dec 31, 2023 10-K 2024-03-21
Q4 2022 $196 K +$190 K +3167% Dec 31, 2022 10-K 2024-03-21
Q4 2021 $6 K -$1.37 M -99.6% Dec 31, 2021 8-K 2023-12-21
Q4 2020 $1.38 M -$194 K -12.3% Dec 31, 2020 10-K 2022-03-08
Q4 2019 $1.57 M +$1.21 M +336% Dec 31, 2019 10-K 2021-03-03
Q4 2018 $361 K +$315 K +685% Dec 31, 2018 10-K 2020-03-03
Q4 2017 $46 K Dec 31, 2017 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.